Pune: There is no reason for people to panic about ‘delta-plus’, the new strain of Coronavirus is called “Variance Concerns”, Dr.
Soumya Swaminathan, Head of the Sacris of the World Health Organization, to Ti on Saturday.
He said who was actively tracking all the SARS-COV-2 variants.
He said, “It is important not to panic over a new virus mutation, which is the evolution of the expected virus.
The Delta variant is one of the worries because it is more contagious than the other strains that we have identified until now.
We track all variants, throughout the world, for Understand whether their characteristics change their ‘behavior’ – whether they cause more severe diseases, more transmitted (transmitted) and whether they develop the ability to avoid vaccines that we have.
“He added,” The good news is, to date, all vaccines Covid-19 proved effective in preventing severe disease and death in people, even where the variant was dominant.
” Dr.
Swaminathan said who did not use the term ‘delta-plus’, which was just said by the Indian government was a ‘variant of concern’.
“We don’t use the term ‘Delta Plus’.
This is a variant of ‘delta’ concerns with an additional spike mutation.
Who tracks this variant (delta-plus) as part of the Delta variant, as we did for another VOC with additional mutations,” he said.
Dr.
Swaminathan said that currently, Delta-Plus doesn’t seem too common, it only takes into account a small portion of the order of delta uploaded to a global initiative about sharing the Avian Influenza (GISAID) database.
The disease control, WHO expert said that India’s plan to overcome delta-plus must be focused on a good genome supervision, including environmental level sequencing.
“We need good genome supervision and strategic sequencing at all levels so we know which variants increase in populations in various parts of the country.
India is a large and diverse country so we need to understand well what happens at the local level,” said Dr.
Swaminathan , He recently emphasized the importance of genetic sequencing.
“It helps us track the mutations themselves.
We know there are certain parts of more critical viruses such as protein surges and receptor binder domains which are also target vaccines.
So if big mutations occur in this domain, it can actually affect the development of vaccines, “Dr.
Swaminathan said during a recent press conference.